Inhibition der Rubellavirus-H�magglutination

Laufs, Rainer; Thomssen, R.

doi:10.1007/bf01241290

Archiv f Virusforschung

1968

DOI: 10.1007/bf01241290

|View full text |Cite

Inhibition der Rubellavirus-H�magglutination

Rainer Laufs

R. Thomssen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1971

1993

Publication Types

Select...

Article6

Relationship

Self Cite3

Independent3

Authors

Journals

Cited by 8 publications

(1 citation statement)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the significance of the low antibody titer detected in HI test was not clear [9]. As the presence of a nonspecific HA inhibitor in normal animal sera was well known in cases of infection with other myxoviruses [2], paramyxoviruses [5,61 and togaviruses [3,11,18], RDE treatment has become to be a common procedure to remove HA inhibitor (s) from human and animal sera in HI tests of these viruses. Parker's original HI method for PVM, however, has not adapted this treatment [161.…”

mentioning

confidence: 99%

Serological Evidence of Pneumonia Virus of Mouse (PVM) Infection in Laboratory Rats

Miyata

Watanabe

Kondo

et al. 1993

Experimental Animals

View full text Add to dashboard Cite

mentioning

confidence: 99%

Serological Evidence of Pneumonia Virus of Mouse (PVM) Infection in Laboratory Rats

Miyata

Watanabe

Kondo

et al. 1993

Experimental Animals

View full text Add to dashboard Cite

Density heterogeneities of hepatitis C virus in human sera due to the binding of ?-lipoproteins and immunoglobulins

Thomssen

Bonk

Thiele

1993

Med Microbiol Immunol

Self Cite

223

184

View full text Add to dashboard Cite

Heterogeneities in the density of hepatitis C virus RNA-carrying material (HCV-RNA-CM) found in human sera (1.03-1.20 g/cm3) are attributed to the binding of low-density lipoproteins and/or of IgG. In some sera HCV-RNA-CM seems to be nearly totally bound to beta-lipoproteins and cannot be precipitated by anti-IgG (gamma); in others more than 95% of HCV-RNA-CM is bound to IgG and cannot be precipitated by anti-beta-lipoprotein. Furthermore, there are sera from which HCV-RNA-CM can be completely be precipitated by either anti-beta-lipoprotein or anti-IgG (gamma), pointing to a binding of the two serum proteins to the same HCV-RNA-CM. There are other sera from which HCV-RNA-CM can be partially precipitated by the one or the other antiserum, leaving behind fractions, which are bound to beta-lipoprotein or to IgG. HCV-RNA-CM cannot be precipitated from some sera either by anti-beta-lipoprotein or by anti-IgG (gamma).

show abstract

Association of hepatitis C virus in human sera with ?-lipoprotein

Thomssen

Bonk

Propfe

et al. 1992

Med Microbiol Immunol

Self Cite

337

266

View full text Add to dashboard Cite

Hepatitis C virus (HCV)-RNA in sera of patients with viral hepatitis C is supposed to be included, at least partially, into HCV particles. We found that the density of HCV-RNA-carrying material was variable, as determined by sucrose gradient density centrifugation (1.03-1.20 g/cm3). In some of the sera examined HCV-RNA was restricted to low densities between 1.03 and 1.08 g/cm3. In other sera additional densities of HCV-RNA were found distributed over the whole gradient with peaks at 1.12 and 1.17 and at 1.19-1.20 g/cm3. HCV-RNA banding at low densities could be completely co-precipitated with anti-beta lipoprotein, whereas HCV-RNA fractions of higher densities were only partially precipitated or not at all. In 8 of 20 sera directly examined, HCV-RNA could be completely and in 9 sera only partially co-precipitated by anti-beta lipoprotein. In 3 sera no significant precipitation could be observed.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Inhibition der Rubellavirus-H�magglutination

Cited by 8 publications

References 7 publications

Serological Evidence of Pneumonia Virus of Mouse (PVM) Infection in Laboratory Rats

Serological Evidence of Pneumonia Virus of Mouse (PVM) Infection in Laboratory Rats

Density heterogeneities of hepatitis C virus in human sera due to the binding of ?-lipoproteins and immunoglobulins

Association of hepatitis C virus in human sera with ?-lipoprotein

Contact Info

Product

Resources

About